CENTERVILLE, MA - October 19, 2010 (Investorideas.com newswire) UV Flu Technologies, Inc. (OTC.BB:UVFT) (the "Company") is pleased to announce that Boston's XV Beacon Hotel has selected the UV-400 bacteria killing air purifier as an added value offering to their guests as a health oriented enhancement available at their multi award winning prestige property.

The XV Beacon Hotel (www.xvbeacon.com) is a 2010 recipient of a Condé Nast award of excellence, and was ranked in 2009 as "#4 Top 20 Business Hotel in the World" by Travel & Leisure Magazine, and "#5 World's Best Small Hotel: US and Canada" by Travel & Leisure Magazine, alongside numerous awards from industry leading advisors such as Fodor's, Forbes Traveller, American Express and many others.

St. Jude Medical and AGA Medical Announce Definitive Agreement

Combination Brings a Significant Addition to St. Jude Medical's Atrial Fibrillation and Cardiovascular Growth Programs

St. Jude Medical Will Discuss the Transaction on Its Third Quarter 2010 Earnings Call Scheduled for 8 a.m. EDT (7 a.m. CDT) on Oct. 20

St. Jude Medical, Inc. (NYSE:STJ - News), a global medical device company, and AGA Medical Holdings, Inc. (Nasdaq:AGAM - News), today announced that the Boards of Directors of both companies have approved a definitive agreement under which St. Jude Medical will acquire all of the outstanding shares of AGA Medical for $20.80 per share in a cash and stock transaction valued at approximately $1.3 billion, including the assumption of approximately $225 million in outstanding debt. The transaction is expected to be conducted as an exchange offer followed by a merger and to close by the end of the year.

CENTERVILLE, MA – October 18, 2010 (InvestorIdeas.com Newswire, www.biotechindustrystocks.com) – Biotech Stock News- UV Flu Technologies, Inc. (OTCBB: UVFT) reports it has been selected as the only air purification medical device to be listed in the Infection Control Segment of the prestigious UK-based opinion and analysis industry publication "Public Service Review." In this, our second appearance for 2010, the Company offers an informative profile within the magazine as well as a full page back cover advertisement.

The Public Service Review features contributors that include UK and foreign ministers, senior civil servants, experts and academics discussing the latest initiatives and projects along with case studies and comments on best practices affecting public sector initiatives worldwide.

CENTERVILLE, MA - October 18, 2010 (Investorideas.com newswire) UV Flu Technologies, Inc. (OTC.BB:UVFT) is pleased to announce that it has been selected as the only air purification medical device to be listed in the Infection Control Segment of the prestigious UK-based opinion and analysis industry publication "Public Service Review." In this, our second appearance for 2010, the Company offers an informative profile within the magazine as well as a full page back cover advertisement.

The Public Service Review features contributors that include UK and foreign ministers, senior civil servants, experts and academics discussing the latest initiatives and projects along with case studies and comments on best practices affecting public sector initiatives worldwide.